About Trutino Biosciences
Trutino Biosciences is a company based in San Diego (United States) founded in 2017 by Phillip S Kim was acquired by Boehringer Ingelheim in June 2022.. Trutino Biosciences offers products and services including Zytokine and ODCs. Trutino Biosciences operates in a competitive market with competitors including Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others.
- Headquarter San Diego, United States
- Founders Phillip S Kim
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Boehringer Ingelheim
(Jun 20, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Trutino Biosciences
Trutino Biosciences offers a comprehensive portfolio of products and services, including Zytokine and ODCs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineered prodrugs for targeted immune activation in cancer treatment.
Conditionally activated therapies to enhance efficacy and reduce toxicity.
Unlock access to complete
Scientist Team
3 people
Product Management Team
2 people
Leadership Team
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of Trutino Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Trutino Biosciences
Trutino Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boehringer Ingelheim. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic drugs and clinical research services are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Trutino Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Trutino Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Trutino Biosciences Comparisons
Competitors of Trutino Biosciences
Trutino Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Selective kinase inhibitors are developed for genomically defined cancers.
|
|
| domain | founded_year | HQ Location |
Targeted therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Trutino Biosciences
Frequently Asked Questions about Trutino Biosciences
When was Trutino Biosciences founded?
Trutino Biosciences was founded in 2017.
Where is Trutino Biosciences located?
Trutino Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Trutino Biosciences?
Phillip S Kim is the current CEO of Trutino Biosciences. They have also founded this company.
What does Trutino Biosciences do?
Trutino Biosciences was founded in 2017 in San Diego, United States. Focus is placed on the biotechnology sector, where cytokines are developed for cancer therapy. These therapeutics are synthesized in inactive forms and activated selectively at tumor sites to support treatment efficacy. Operations center on advancing such targeted drug innovations for oncology applications.
Who are the top competitors of Trutino Biosciences?
Trutino Biosciences's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and argenx.
What products or services does Trutino Biosciences offer?
Trutino Biosciences offers Zytokine and ODCs.
Who are Trutino Biosciences's investors?
Trutino Biosciences has 1 investor. Key investors include Boehringer Ingelheim.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.